Literature DB >> 6742819

Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics.

L Dubreuil, J Devos, C Neut, C Romond.   

Abstract

The in vitro activity of cefoxitin was compared with those of metronidazole and clindamycin against 322 strains of anaerobic bacteria collected from several hospitals during 1982 and tested by an agar dilution method. Metronidazole and cefoxitin inhibited at least 89% of strains tested, whereas clindamycin was less active.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6742819      PMCID： PMC185637          DOI： 10.1128/AAC.25.6.764

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  29 in total

1.  Susceptibility of anaerobic bacteria to Sch 29482.

Authors:  V L Sutter; Y Y Kwok; S M Finegold
Journal:  J Antimicrob Chemother       Date:  1982-02       Impact factor: 5.790

2.  A survey of Bacteroides susceptibility in the United States.

Authors:  G Cuchural; N Jacobus; S L Gorbach; F P Tally
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

3.  Resistance pattern of anaerobic bacteria isolated in a general hospital during a two-year period.

Authors:  J F Acar; F W Goldstein; M D Kitzis; M T Eyquem
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

4.  Activity in vitro of cefotetan against non-sporing anaerobes: a comparative study.

Authors:  G Ruckdeschel
Journal:  J Antimicrob Chemother       Date:  1983-01       Impact factor: 5.790

5.  Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics.

Authors:  T Kesado; K Watanabe; Y Asahi; M Isono; K Ueno
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

6.  Bacteriological comparison of the activities of ceftriaxone, a new long-acting cephalosporin, with those of other new cephalosporins.

Authors:  M Arisawa; J Ohshima; E Ohsawa; H B Maruyama; Y Sekine; S Mitsuhashi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1982-07       Impact factor: 1.645

7.  Susceptibility of the Bacteroides fragilis group in the United States in 1981.

Authors:  F P Tally; G J Cuchural; N V Jacobus; S L Gorbach; K E Aldridge; T J Cleary; S M Finegold; G B Hill; P B Iannini; R V McCloskey; J P O'Keefe; C L Pierson
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

8.  Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.

Authors:  L W Ayers; R N Jones; A L Barry; C Thornsberry; P C Fuchs; T L Gavan; E H Gerlach; H M Sommers
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

9.  Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.

Authors:  D Sofianou; J Douboyas; J Papapanagiotou; A G Paradelis
Journal:  Methods Find Exp Clin Pharmacol       Date:  1982

10.  In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.

Authors:  J E Brown; V E Del Bene; C D Collins
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191
View more
  16 in total

1.  In vitro susceptibilities of the Bacteroides fragilis group to 14 antimicrobial agents in Korea.

Authors:  K Lee; I H Jang; Y J Kim; Y Chong
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

Review 2.  Susceptibility testing of anaerobic bacteria: myth, magic, or method?

Authors:  H M Wexler
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

3.  Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992.

Authors:  L Dubreuil; J Breuil; A Dublanchet; A Sedallian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

4.  Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology.

Authors:  K E Aldridge; H M Wexler; C V Sanders; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

5.  Susceptibilities of Bacteroides and Fusobacterium spp. from foot rot in goats to 10 beta-lactam antibiotics.

Authors:  S Piriz Duran; J Valle Manzano; R Cuenca Valera; S Vadillo Machota
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

6.  Disk diffusion susceptibility testing of the Bacteroides fragilis group.

Authors:  R Horn; A M Bourgault; F Lamothe
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

Review 7.  Evolution in antibiotic susceptibility of Bacteroides fragilis group strains in France based on periodic surveys.

Authors:  L Dubreuil; M Derriennic; A Sedallian; C Romond; A L Courtieu
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

8.  Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.

Authors:  C Betriu; E Campos; C Cabronero; C Rodriguez-Avial; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

9.  Belgian Collaborative Study of the in-vitro susceptibility of the Bacteroides fragilis group. A Belgian Collaborative Study Group.

Authors: 
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082

10.  Effect of antibiotics on toxin production and viability of Clostridium perfringens.

Authors:  D L Stevens; K A Maier; J E Mitten
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.